|Bid||0.5500 x N/A|
|Ask||0.6100 x N/A|
|Day's Range||0.5400 - 0.6100|
|52 Week Range||0.1900 - 0.6400|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Announced that the U.S. Food and Drug Administration has approved the Company’s Investigational New ...
Announced that its wholly-owned subsidiary, PharmaTher has entered into an exclusive license agreement ...
A wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) announced it has entered into ...